Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Infiltrating Glioblastoma Via pH Sensitive Visualization of Tumor and pH Modulation Through Bicarbonate Transporter SLC4A4

NCT07218367 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT07218367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07218367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Infiltrating Glioblastoma Via pH Sensitive Visualization of Tumor and pH Modulation Through Bicarbonate Transporter SLC4A4
Lead sponsor
VA Office of Research and Development
Phase
Phase 1
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
July 1, 2031
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma